Dr. Mahmoud Refat Altawil, MD

Dr. Altawil practices at AdventHealth Medical Group in Orlando, Florida.

Dr. Altawil's NPI, 1104264308, was assigned on June 10, 2013. Dr. Altawil graduated from University of Miami, Miller School of Medicine in 2013. Dr. Altawil holds Florida license ME150633.

Dr. Altawil's primary practice is AdventHealth Medical Group, at 1613 N Mills Ave, Orlando, FL 32803 in Orange County. The practice phone is (407) 841-1100.

Dr. Altawil's primary practice is AdventHealth Medical Group in Orlando, Florida. Dr. Altawil is also affiliated with AdventHealth Orlando. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Altawil to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Altawil practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Altawil's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Altawil is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Altawil's licenses on file in 2 states: Florida and Michigan.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, coronary artery disease and heart blockage among the conditions Dr. Altawil treats.

CMS data shows 1,173 Medicare services from Dr. Altawil across 19 procedure codes in 2024, for 295 Medicare patients. Medicare paid $75,141 for them.

CMS counts 295 Medicare patients who saw Dr. Altawil in 2024. The largest group is 65 to 74, with 112 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Altawil's median patient age at 71, with 45% women.

In 2024, Dr. Altawil wrote 394 Medicare Part D claims for 117 patients. 78% of them were for generic drugs. CMS names the drug for 292 of them, across 12 drugs with 11 or more claims each, at $62,477 in total drug cost. In 2023, CMS named 169 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Altawil for performance year 2024, reported as part of a group. Dr. Altawil accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of pacemaker insertion or repair by Dr. Altawil, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Altawil, published from 2018 to 2024. 2020 was the busiest year, with 2. Dr. Altawil's most frequent co-authors are Joshua C. Greenberg, MD, Waddah Maskoun, MD and Elsheikh Mamoun Elsheikh Abdelrahim.

CMS Open Payments shows 350 general payments to Dr. Altawil from 17 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 47% of the total. Boston Scientific Corporation paid the most, $14,399.

Dr. Altawil graduated from University of Miami, Miller School of Medicine in 2013.

Dr. Altawil is in network with 18 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.